Drug Risks

<span style="font-weight: 400;">The Ninth Circuit <a href="http://www.courthousenews.com/wp-content/uploads/2020/02/drugrisks.pdf"><strong>affirmed</strong></a> the dismissal of negligence claims against the makers of the antidepressant drug Lexapro, finding that the drug’s packaging contained clear warning labels about a heightened risk of suicide for adolescents. </span>

SAN FRANCISCO – The Ninth Circuit affirmed the dismissal of negligence claims against the makers of the antidepressant drug Lexapro, finding that the drug’s packaging contained clear warning labels about a heightened risk of suicide for adolescents.

Categories / Appeals, Business, Health

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.